Impact of NIH Funding Cuts on Drug Development

Last week, the Congressional Budget Office (CBO) released a report titled “How Changes to Funding for the NIH and Changes in the FDA’s Review Times Would Affect the Development of New Drugs.” The report evaluates two scenarios: A permanent 10 percent reduction in the amount of funding that the government provides to the NIH, andA…

Read More

Imagine Reshaping The Surgical Landscape With Autonomous Surgery

To prepare for an autonomous surgical future, medtech leaders should explore the practical implications of potential scenarios, and structure investment accordingly. The key is to develop a living roadmap that drives decisions on a day-by-day basis, drawing on macro- and micro-trends. The post Imagine Reshaping The Surgical Landscape With Autonomous Surgery appeared first on MedCity…

Read More

Gobierno prometió “transparencia radical”, pero oculta solicitudes de fondos para la salud rural

Drones que entregan medicamentos y telesalud en bibliotecas locales son algunas de las ideas que líderes estatales acaban de presentar para gastar su parte de un programa federal de salud rural de $50.000 millones. El gobierno de Trump, que ha prometido “transparencia radical”, afirmó en un documento de preguntas frecuentes que planea publicar el “resumen…

Read More

Seriously, Aon, you think weight loss drugs save money?

By AL LEWIS Last month Aon, the major benefits consulting firm, released a “study” claiming: A significant opportunity to reduce healthcare costs for employers and enhance overall workforce health through a comprehensive obesity management program that includes GLP-1 medications. This, of course, is the opposite of what most researchers have shown.  And in the immortal…

Read More